novo nordisk glp-1 patent litigation Landscape: Shifting Dimensions Beyond Diabetes Novo, Lilly Patent Moves Keep
Description
Patients on GLP-1 medications are at higher risk of muscle loss if protein intake is too low
South America Prescription Drug Market Challenges 3.6.1
Understanding the characteristics and features of these devices can therefore aid both physicians and their patients in selecting the most appropriate agent
Chromium, in particular, plays an important role in helping the body maintain stable blood sugar levels, which is closely connected to healthy GLP-1 activity
On average, patients regain about 60% of the weight they lost within a few months to a year after stopping the medication, even when maintaining healthy habits like proper nutrition and exercise
Access, cost and insurance concerns represented another persistent theme, accounting for approximately 12% of thematic discussion
